Extraventricular neurocytomas: A morphological and histogenetic consideration. A study of six cases

Pathology

Volumn 43, Issue 4, 2011, Pages 327-334

  Agarwal, Shipra ^a   Sharma, Mehar Chand ^a   Sarkar, Chitra ^a   Suri, Vaishali ^a   Jain, Ayushi ^a   Sharma, Manish Singh ^b   Ailawadhi, Pankaj ^b   Garg, Ajay ^c   Mallick, Supriya ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Neurosurgery   (India)

^c Departments of MRI Neuroradiology   (India)

Author keywords

19q; 1p; Extraventricular; FISH; IDH1; Neurocytoma; Oligodendroglioma

Indexed keywords

EID: 80052253728     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283463f97     Document Type: Article

References (49)

1. Hassoun J, Gambarelli D, Grisoli F, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 1982; 56: 151-6.
2. Kleihues P, Louis DN, Wiestler OD, et al. WHO grading of tumours of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC, 2007; 10-11.
3. Sharma MC, Deb P, Sharma S, et al. Neurocytoma: a comprehensive review. Neurosurg Rev 2006; 29: 270-85. (Pubitemid 44379653)
4. Sharma S, Sarkar C, Gaikwad S, et al. Primary neurocytoma of the spinal cord: a case report and review of literature. J Neurooncol 2005; 74: 47-52. (Pubitemid 41194530)
5. Singh A, Chand K, Singh H, et al. Atypical neurocytoma of the spinal cord in a young child. Childs Nerv Syst 2007; 23: 207-11. (Pubitemid 46055888)
6. Zentner J, Peiffer J, Roggendorf W, et al. Periventricular neurocytoma: a pathological entity. Surg Neurol 1992; 38: 38-42.
7. Giangaspero F, Cenacchi G, Losi L, et al. Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol 1997; 21: 206-12. (Pubitemid 27084061)
8. Brat DJ, Scheithauer BW, Eberhart CG, et al. Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 2001; 25: 1252-60. (Pubitemid 32917118)
9. Jay V, Edwards V, Hoving E, et al. Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses. Case report. J Neurosurg 1999; 90: 348-54. (Pubitemid 29068138)
10. Yin XL, Pang JC, Hui AB, et al. Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. J Neurosurg 2000; 93: 77-81. (Pubitemid 30457326)
11. Tong CY, Ng HK, Pang JC, et al. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas. Histopathology 2000; 37: 160-5. (Pubitemid 30608515)
12. Fujisawa H, Marukawa K, Hasegawa M, et al. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J Neurosurg 2002; 97: 1350-5. (Pubitemid 35424290)
13. Perry A, Fuller CE, Banerjee R, et al. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 2003; 8: a1-9. (Pubitemid 39069937)
14. Leenstra JL, Rodriguez FJ, Frechette CM, et al. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 2007; 67: 1145-54.
15. Mrak RE, Yasargil MG, Mohapatra G, et al. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. Hum Pathol 2004; 35: 1156-9. (Pubitemid 39165349)
16. Rodriguez FJ, Mota RA, Scheithauer BW, et al. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol 2009; 19: 623-9.
17. Makuria AT, Henderson FC, Rushing EJ, et al. Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor. J Neurooncol 2007; 82: 199-205. (Pubitemid 46431866)
18. Takeuchi H, Kubota T, Kitai R, et al. Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component. J Neurooncol 2009; 91: 33-8.
19. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765-73.
20. Hartmann C, Meyer J, Balss J, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009; 118: 469-74.
21. Ichimura K, Pearson DM, Kocialkowski S, et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro oncol 2009; 11: 341-7.
22. Raghavan R, Balani J, Perry A, et al. Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 2003; 62: 530-7. (Pubitemid 36560194)
23. Ng HK, Ko HCW, Tse CCH. Immunohistochemical and ultrastructural studies of oligodendrogliomas revealed features of neuronal differentiation. Int J Surg Pathol 1994; 2: 47-56. (Pubitemid 2125859)
24. Wharton SB, Chan KK, Hamilton FA, et al. Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study. Neuropathol Appl Neurobiol 1998; 24: 302-8. (Pubitemid 28389127)
25. Mut M, Güler-Tezel G, Lopes MB, et al. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma. Clin Neuropathol 2005; 24: 225-9. (Pubitemid 41277339)
26. Perry A, Scheithauer BW, Macaulay RJ, et al. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 2002; 61: 947-55. (Pubitemid 35278716)
27. Cenacchi G, Giangaspero F, Cerasoli S, et al. Ultrastructural characterization of oligodendroglial-like cells in central nervous system tumors. Ultrastruct Pathol 1996; 20: 537-47. (Pubitemid 26414469)
28. Mrak RE. The Big Eye in the 21st century: the role of electron microscopy in modern diagnostic neuropathology. J Neuropathol Exp Neurol 2002; 61: 1027-39. (Pubitemid 35435021)
29. Sharma MC, Rathore A, Karak AK, et al. A study of proliferative markers in central neurocytoma. Pathology 1998; 30: 355-9. (Pubitemid 28499641)
30. Figarella-Branger D, Pellissier JF, Daumas-Duport C, et al. Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol 1992; 16: 97-109.
31. Söylemezoglu F, Scheithauer BW, Esteve J, et al. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997; 56: 551-6. (Pubitemid 27463096)
32. von Deimling A, Janzer R, Kleihues P, et al. Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 1990; 79: 473-9.
33. Schweitzer JB, Davies KG. Differentiating central neurocytoma. Case report. J Neurosurg 1997; 86: 543-6. (Pubitemid 27097103)
34. Figarella-Branger D, Söylemezoglu F, Burger PC. Central neurocytoma and extraventricular neurocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC, 2007; 108.
35. Westphal M, Meissner H, Matschke J, et al. Tissue culture of human neurocytomas induces the expression of glial fibrilary acidic protein. J Neurocytol 1998; 27: 805-16. (Pubitemid 29441058)
36. Vaquero J, Coca S,Moreno M, et al. Expression of neuronal and glial markers in so-called oligodendroglial tumors induced by transplacentaladministration of ethyl-nitrosourea in the rat. Histol Histopathol 1992; 7: 647-51.
37. Sim FJ, Keyoung HM, Goldman JE, et al. Neurocytoma is a tumor of adult neuronal progenitor cells. J Neurosci 2006; 26: 12544-55. (Pubitemid 44864519)
38. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90: 1473-9. (Pubitemid 28482012)
39. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003; 62: 111-26. (Pubitemid 36176946)
40. Aldape K, Burger PC, Perry A. Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Arch Pathol Lab Med 2007; 131: 242-51.
41. Marucci G, Barbanera A, Serchi E, et al. Ganglioneurocytoma of the spinal cord: report of a case and review of literature. Eur Spine J 2009; 18 (Suppl 2): 183-5.
42. Tatter SB, Borges LF, Louis DN. Correction: central neurocytomas of cervical spinal cord. J Neurosurg 1995; 82: 706.
43. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-12.
44. Horbinski C, Kofler J, Kelly LM, et al. Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 2009; 68: 1319-25.
45. Capper D, Zentgraf H, Balss J, et al. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 2009; 118: 599-601.
46. Camelo-Piragua S, Jansen M, Ganguly A, et al. Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis. Acta Neuropathol 2010; 119: 509-11.
47. Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 2009; 27: 4150-4.
48. Bleeker FE, Atai NA, Lamba S, et al. The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol 2010; 119: 487-94.
49. Capper D, Weissert S, Balss J, et al. Characterization of R132H mutationspecific IDH1 antibody binding in brain tumors. Brain Pathol 2010; 20: 245-54.